Articles

Jul 18, 2018
Cytox White Paper on Assessing Alzheimer’s disease risk using polygenic risk scoring biomarkers
Mar 6, 2017
Cytox’s breakthrough polygenic risk scoring approach for assessing Alzheimer’s disease risk poised to accelerate therapeutic targeting. See BioCentury’s report on ‘Diagnosing AD Trials’